S. Daar

发表

HbS-oman heterozygote: a new dominant sickle syndrome.

R. Nagel, R. Schwartz, E. Bouhassira, 1998, Blood.

Improved diagnosis of sickle cell mutation by a robust amplification refractory polymerase chain reaction.

M. Simsek, R. Bayoumi, S. Daar, 1999, Clinical biochemistry.

Noninvasive assessment and risk factors of liver fibrosis in patients with thalassemia major using shear wave elastography

S. Al-Busafi, S. Daar, M. Al-Khabori, 2018, Hematology.

Fluctuating antibody response in a cohort of hepatitis C patients.

S. Daar, S. A. Al Dhahry, Jameel C Nograles, 2002, Journal for scientific research. Medical sciences.

HbS-oman heterozygote: a new dominant sickle syndrome.

R. Nagel, R. Schwartz, E. Bouhassira, 1998, Blood.

Long-Term Follow-up of β-Transfusion-Dependent Thalassemia (TDT) Normoglycemic Patients with Reduced Insulin Secretion to Oral Glucose Tolerance Test (OGTT): A Pilot Study

V. De Sanctis, A. Soliman, C. Kattamis, 2021, Mediterranean journal of hematology and infectious diseases.

Non-invasive haemoglobin estimation in patients with thalassaemia major.

S. Daar, K. al-Farsi, A. Al-Riyami, 2014, Sultan Qaboos University medical journal.

Serum ferritin values between 300 and 800 ng/mL in nontransfusion‐dependent thalassemia: A probability curve to guide clinical decision making when MRI is unavailable

M. Cappellini, V. Viprakasit, G. Graziadei, 2017, American journal of hematology.

Serum ferritin level and morbidity risk in transfusion-independent patients with β-thalassemia intermedia: the ORIENT study

M. Cappellini, G. Graziadei, A. Taher, 2014, Haematologica.

Risk factors for pulmonary hypertension in patients with β thalassemia intermedia.

M. Cappellini, S. Temraz, A. Taher, 2011, European journal of internal medicine.

Overview on practices in thalassemia intermedia management aiming for lowering complication rates across a region of endemicity: the OPTIMAL CARE study.

M. Cappellini, A. Taher, A. El‐Beshlawy, 2010, Blood.

A community-based study of common hereditary blood disorders in Oman.

A. Al-Riyami, M. Afifi, S. Daar, 2001, Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit.

Glucose Metabolism and Insulin Response to Oral Glucose Tolerance Test (OGTT) in Prepubertal Patients with Transfusion-Dependent β-thalassemia (TDT): A Long-Term Retrospective Analysis

V. De Sanctis, A. Soliman, C. Kattamis, 2021, Mediterranean journal of hematology and infectious diseases.

Splenectomy for haematological disorders: a single center study in 150 patients from Oman.

S. Daar, N. Machado, S. Alkindi, 2009, International journal of surgery.

Correlation of Iron Overload and Glomerular Filtration Rate Estimated by Cystatin C in Patients with β-Thalassemia Major

S. Bhandari, S. Daar, M. Al-Khabori, 2014, Hemoglobin.

Review and Recommendations on Management of Adult Female Thalassemia Patients with Hypogonadism based on Literature Review and Experience of ICET-A Network Specialists

V. De Sanctis, A. Soliman, S. A. Al Jaouni, 2016, Mediterranean journal of hematology and infectious diseases.

Prevalence of Hepatitis C among Multi-transfused Thalassaemic Patients in Oman: Single centre experience.

I. Al-Zakwani, S. Daar, K. Al-Naamani, 2015, Sultan Qaboos University medical journal.

Marital status and paternity in patients with Transfusion-Dependent Thalassemia (TDT) and Non Transfusion-Dependent Thalassemia (NTDT): an ICET - A survey in different countries

V. De Sanctis, A. Soliman, M. Karimi, 2019, Acta bio-medica : Atenei Parmensis.

An ICET- A survey on hypoparathyroidism in patients with thalassaemia major and intermedia: a preliminary report

V. De Sanctis, S. A. Al Jaouni, M. Karimi, 2018, Acta bio-medica : Atenei Parmensis.

Association between cardiac T2* magnetic resonance imaging values and endocrine function tests in patients with β-thalassemia major.

A. Taher, A. Pathare, S. Daar, 2014, Blood Cells, Molecules & Diseases.

Cardiac T2* MR in patients with thalassemia major: a 10-year long-term follow-up

D. Pennell, S. Daar, Moez Hassan, 2020, Annals of Hematology.

A study of isolated hyperglycemia (blood glucose ≥155 mg/dL) at 1-hour of oral glucose tolerance test (OGTT) in patients with β-transfusion dependent thalassemia (β-TDT) followed for 12 years

V. De Sanctis, A. Soliman, C. Kattamis, 2021, Acta bio-medica : Atenei Parmensis.

Transfusion in Haemoglobinopathies: Review and recommendations for local blood banks and transfusion services in Oman.

S. Daar, A. Al-Riyami, 2018, Sultan Qaboos University medical journal.

Aetiological profile of women presenting with premature ovarian failure to a single tertiary care center in Oman

A. Pathare, S. Daar, V. Gowri, 2015, Post reproductive health.

Cytokine profile of sickle cell disease in Oman

A. Pathare, H. Knox-macaulay, S. Daar, 2004, American journal of hematology.

Pancreatic changes affecting glucose homeostasis in transfusion dependent β-thalassemia (TDT): a short review

V. De Sanctis, A. Soliman, C. Kattamis, 2021, Acta bio-medica : Atenei Parmensis.

Improved Treatment Satisfaction and Convenience with Deferasirox in Iron-Overloaded Patients with β-Thalassemia: Results from the ESCALATOR Trial

A. Taher, A. El‐Beshlawy, Mohsen Saleh Elalfy, 2010, Acta Haematologica.

Deferasirox (Exjade®) significantly improves cardiac T2* in heavily iron-overloaded patients with β-thalassemia major

A. Taher, A. Pathare, S. Daar, 2008, Annals of Hematology.

The pneumatic tube system does not affect complete blood count results; a validation study at a tertiary care hospital

S. Alkindi, S. Daar, M. Al-Khabori, 2014, International journal of laboratory hematology.

T2* MRI in Regularly Transfused Children with Thalassemia Intermedia: Serum Ferritin Does Not Reflect Liver Iron Stores

S. Daar, Y. Wali, M. Al-Khabori, 2012, Pediatric hematology and oncology.

Red cell alloimmunization in transfusion-dependent and transfusion-independent beta thalassemia: A review from the Eastern Mediterranean Region (EMRO).

S. Daar, A. Al-Riyami, A. Al‐Riyami, 2019, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

Transfusion therapy and alloimmunization in Thalassemia Intermedia: a 10 year experience at a tertiary care university hospital.

S. Daar, A. Al-Riyami, A. Al-Madhani, 2014, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

Prepubertal Hypertransfusion in Thalassemia Intermedia: A Case Report of Sustained Positive Effects on Growth, Splenic Function and Endocrine Parameters.

S. Daar, Y. Wali, M. Zachariah, 2012, Oman medical journal.

M. Cappellini, G. Graziadei, A. Taher, 2010, British journal of haematology.

Hypogonadism in male thalassemia major patients: pathophysiology, diagnosis and treatment

V. De Sanctis, A. Soliman, C. Kattamis, 2018, Acta bio-medica : Atenei Parmensis.

Single Breath-Hold Physiotherapy Technique: Effective tool for T2* magnetic resonance imaging in young patients with thalassaemia major.

S. Daar, Y. Wali, M. Zachariah, 2016, Sultan Qaboos University medical journal.

Evolution of combined impaired fasting glucose and impaired glucose tolerance in β-thalassemia major: Results in 58 patients with a mean 7.7- year follow-up

V. De Sanctis, A. Soliman, C. Kattamis, 2022, Acta bio-medica : Atenei Parmensis.

The use of oral glucose-lowering agents (GLAs) in β-thalassemia patients with diabetes: Preliminary data from a retrospective study of ICET-A Network

T. Zarei, V. De Sanctis, A. Soliman, 2022, Acta bio-medica : Atenei Parmensis.

T2* cardiovascular magnetic resonance in the management of thalassemia patients in Oman

D. Pennell, A. Pathare, R. Jain, 2009, Haematologica.

First reported case of compound heterozygosity for HbA2-Yialousa (HBD: c.82 G>C) and HbA2-Wrens (HBD: c.295 G>A) in Oman

S. Daar, D. Gravell, Y. Wali, 2013, International Journal of Hematology.

Hb A2′ (Hb B2) in the Omani Population and Diagnostic Significance

T. Berbar, R. Krishnamoorthy, S. Daar, 2011, Hemoglobin.

Diagnosis of Beta-thalassaemia carriers in the sultanate of oman.

S. Daar, D. Gravell, 2006, Sultan Qaboos University medical journal.

Primary HBB gene mutation severity and long‐term outcomes in a global cohort of β‐thalassaemia

G. Dardanoni, E. Vichinsky, A. Meloni, 2021, British journal of haematology.

Myxedema coma in children and adolescents: A rare endocrine emergency - Personal experience and review of literature

V. De Sanctis, A. Soliman, C. Kattamis, 2021, Acta bio-medica : Atenei Parmensis.

Thyroid Disorders in Homozygous β-Thalassemia: Current Knowledge, Emerging Issues and Open Problems

V. De Sanctis, A. Soliman, D. Canatan, 2019, Mediterranean journal of hematology and infectious diseases.

Evolution of glucose-insulin homeostasis in children with β- thalassemia major (β -TM): A twenty-year retrospective ICET- A observational analysis from early childhood to young adulthood

V. De Sanctis, A. Soliman, M. Karimi, 2022, Acta bio-medica : Atenei Parmensis.

Screening for glucose dysregulation in β-thalassemia major (β-TM): An update of current evidences and personal experience

V. De Sanctis, A. Soliman, M. Karimi, 2022, Acta bio-medica : Atenei Parmensis.

Genetic epidemiology of HbS in Oman: Multicentric origin for the βS gene

R. Nagel, R. Krishnamoorthy, S. Daar, 2000 .

Reduction in labile plasma iron during treatment with deferasirox, a once-daily oral iron chelator, in heavily iron-overloaded patients with β-thalassaemia

A. Taher, A. Pathare, A. Hmissi, 2009, European journal of haematology.

General principles of good transition care: a short review of the literature

S. Bernasconi, M. Angastiniotis, A. Soliman, 2015 .

Haemoglobin Fontainebleau (HBA2: c. 64G>C) in Oman: molecular and haematological characteristics and interaction with various haemoglobinopathies

S. Daar, Y. Wali, A. Al-Riyami, 2017, Journal of Clinical Pathology.

Potential pitfalls in the diagnosis of Hb Handsworth in areas with high prevalence of HbS

S. Daar, D. Gravell, A. Al-Riyami, 2014, International journal of laboratory hematology.

Understanding Iron Metabolism: Lessons from Transfusion-dependent Thalassemia.

S. Daar, M. Al-Khabori, 2018, Oman medical journal.

Current Issues and Options for Hormonal Contraception in Adolescents and Young Adult Women With Sickle Cell Disease: An Update for Health Care Professionals

V. De Sanctis, A. Soliman, D. Canatan, 2020, Mediterranean journal of hematology and infectious diseases.

Side effects of Deferasirox Iron Chelation in Patients with Beta Thalassemia Major or Intermedia.

S. Bhandari, S. Daar, M. Al-Khabori, 2013, Oman medical journal.

Oral glucose tolerance test: how to maximize its diagnostic value in children and adolescents

V. De Sanctis, A. Soliman, C. Kattamis, 2022, Acta bio-medica : Atenei Parmensis.

Frequency and clinical significance of erythrocyte genetic abnormalities in Omanis.

D. Higgs, B. Christie, S. Daar, 1993, Journal of medical genetics.

Mediterranean Journal of Hematology and Infectious Diseases Β-thalassemia Distribution in the Old World: an Ancient Disease Seen from a Historical Standpoint

M. Angastiniotis, V. De Sanctis, A. Soliman, 2022 .

Insulin-like growth factor -1 (IGF-1) and glucose dysregulation in young adult patients with β-thalassemia major: causality or potential link?

V. De Sanctis, A. Soliman, C. Kattamis, 2022, Acta bio-medica : Atenei Parmensis.

Clinical characteristics, biochemical parameters and insulin response to oral glucose tolerance test (OGTT) in 25 transfusion dependent β-thalassemia (TDT) patients recently diagnosed with diabetes mellitus (DM)

V. De Sanctis, A. Soliman, M. Karimi, 2022, Acta bio-medica : Atenei Parmensis.

Prevalence of glucose dysregulation (GD) in patients with β-thalassemias in different countries: A preliminary ICET-A survey

V. De Sanctis, A. Soliman, S. A. Al Jaouni, 2021, Acta bio-medica : Atenei Parmensis.

The ICET-A Recommendations for the Diagnosis and Management of Disturbances of Glucose Homeostasis in Thalassemia Major Patients

M. Angastiniotis, V. De Sanctis, A. Soliman, 2016, Mediterranean journal of hematology and infectious diseases.

Hematopoietic stem cell transplantation in Oman

J. Rehman, A. Pathare, S. Daar, 2008, Bone Marrow Transplantation.

Primary pseudomonas meningitis in an adult, splenectomized, multitransfused thalassaemia major patient.

S. Daar, D. Hiwase, K. Ghosh, 2000, Haematologia.

Coronavirus Disease 2019 (COVID-19) in adolescents: An update on current clinical and diagnostic characteristics

V. De Sanctis, A. Soliman, C. Kattamis, 2020, Acta bio-medica : Atenei Parmensis.

Risks of red blood cell alloimmunization in transfusion‐dependent β‐thalassemia in Oman: a 25‐year experience of a university tertiary care reference center and a literature review

S. Daar, A. Al-Riyami, M. Zacharia, 2018, Transfusion.

Splenectomy and thrombosis: the case of thalassemia intermedia

A T Taher, K M Musallam, M Karimi, 2010, Journal of thrombosis and haemostasis : JTH.

Development of a Thalassemia International Prognostic Scoring System (TIPSS).

Filippo Cademartiri, G. Dardanoni, E. Vichinsky, 2022, Blood cells, molecules & diseases.

α-Globin Genotypes Associated with Hb H Disease: A Report from Oman and a Review of the Literature from the Eastern Mediterranean Region

S. Daar, Y. Wali, A. Al-Riyami, 2020, Hemoglobin.

Cytokines in Sickle Cell Disease

A. Pathare, S. Daar, D. Dennison, 2003, Hematology.

Molecular characterization of G6PD deficiency in Oman.

T. Vulliamy, L. Luzzatto, P. Mason, 1996, Human heredity.

Thalassaemia—A global view

S. Sheth, A. Taher, P. Hokland, 2023, British journal of haematology.

Efficacy and safety of deferasirox, an oral iron chelator, in heavily iron-overloaded patients with β-thalassaemia: the ESCALATOR study

A. Taher, A. El‐Beshlawy, Mohsen Saleh Elalfy, 2009, European journal of haematology.

Alloimmunization in Patients with Sickle Cell Disease and Thalassemia: Experience of a Single Centre in Oman

A. Pathare, N. Fawaz, S. Alkindi, 2017, Mediterranean journal of hematology and infectious diseases.

Forecasting Hemoglobinopathy Burden Through Neonatal Screening in Omani Neonates

T. Berbar, A. Pathare, R. Krishnamoorthy, 2010, Hemoglobin.

Spectrum of β‐Thalassemia Mutations in Oman a

T. Merghoub, R. Krishnamoorthy, S. Daar, 1998 .

Abnormal diastolic function and Global longitudinal strain in patients with Thalassemia Major on long term chelation therapy

S. Daar, W. Abdelmottaleb, S. Nadar, 2020, The International Journal of Cardiovascular Imaging.

Morbidity-free survival and hemoglobin level in non-transfusion-dependent β-thalassemia: a 10-year cohort study

M. Cappellini, A. Taher, S. Daar, 2021, Annals of Hematology.

Risk of mortality from anemia and iron overload in nontransfusion‐dependent β‐thalassemia

G. Dardanoni, E. Vichinsky, A. Meloni, 2021, American journal of hematology.

Survival and causes of death in 2,033 patients with non-transfusion-dependent β-thalassemia

G. Dardanoni, E. Vichinsky, A. Meloni, 2021, Haematologica.

Preliminary Data on COVID-19 in Patients with Hemoglobinopathies: A Multicentre ICET-A Study

Y. Oymak, T. Zarei, V. De Sanctis, 2020, Mediterranean journal of hematology and infectious diseases.

Glucose Homeostasis and Assessment of β-Cell Function by 3-hour Oral Glucose Tolerance (OGTT) in Patients with β-Thalassemia Major with Serum Ferritin below 1,000 ng/dL: Results from a Single ICET-A Centre

V. De Sanctis, A. Soliman, C. Kattamis, 2023, Mediterranean journal of hematology and infectious diseases.

A complication risk score to evaluate clinical severity of thalassaemia syndromes

G. Dardanoni, E. Vichinsky, A. Meloni, 2020, British journal of haematology.

A stepwise α‐thalassemia screening strategy in high‐prevalence areas

A. Srivastava, A. Pathare, S. Alkindi, 2013, European journal of haematology.

Severity ranking of non‐deletional alpha thalassemic alleles: insights from an Omani family study

N. Fawaz, Siham Alsinani, R. Krishnamoorthy, 2011, European journal of haematology.

Haematological and clinical features of β‐thalassaemia associated with Hb Dhofar

A. Pathare, R. Krishnamoorthy, S. Daar, 2007, European journal of haematology.

Genetic epidemiology of HbS in Oman: multicentric origin for the betaS gene.

R. Nagel, R. Krishnamoorthy, S. Daar, 2000, American journal of hematology.

Spectrum of beta-thalassemia mutations in Oman.

T. Merghoub, R. Krishnamoorthy, S. Daar, 1998, Annals of the New York Academy of Sciences.

Random Forest Clustering Identifies Three Subgroups of β-Thalassemia with Distinct Clinical Severity

G. Dardanoni, E. Vichinsky, A. Meloni, 2022, Thalassemia Reports.

Chemical composition andtissue distribution ofthe humanCDw44glycoprotein

J. Fabre, R. Dalchau, S. Daar, 1989 .

Prevalence, attitude and practice of self-medication among adolescents and the paradigm of dysmenorrhea self-care management in different countries

V. De Sanctis, A. Soliman, C. Kattamis, 2020, Acta bio-medica : Atenei Parmensis.

Plasma LPI in β-Thalassemia Patients before and after Treatment with Deferasirox (Exjade®, ICL670).

A. Taher, A. Pathare, S. Daar, 2005 .

Multicenter Validation of Spin-Density Projection-Assisted R2-MRI for the Noninvasive Measurement of Liver Iron Concentration

Tim G St Pierre, Amal El-Beshlawy, Mohsen Elalfy, 2013, Magnetic resonance in medicine.

Achieving treatment goals of reducing or maintaining body iron burden with deferasirox in patients with β-thalassaemia: results from the ESCALATOR study

Amal El-Beshlawy, Abdullah Al Jefri, Kusai Al Zir, 2011, European journal of haematology.

Importance of optimal dosing ≥30 mg/kg/d during deferasirox treatment: 2.7-yr follow-up from the ESCALATOR study in patients with β-thalassaemia

Amal El-Beshlawy, Abdullah Al Jefri, Kusai Al Zir, 2011, European journal of haematology.

Safety of stem cell mobilization in donors with sickle cell trait

S. Daar, M. Al-Khabori, K. al-Farsi, 2014, Bone Marrow Transplantation.

Combined therapy with desferrioxamine and deferiprone in beta thalassemia major patients with transfusional iron overload

A. Pathare, S. Daar, 2006, Annals of Hematology.

A Concise Review on the Frequency, Major Risk Factors and Surveillance of Hepatocellular Carcinoma (HCC) in β-Thalassemias: Past, Present and Future Perspectives and the ICET-A Experience

V. De Sanctis, A. Soliman, S. A. Al Jaouni, 2020, Mediterranean journal of hematology and infectious diseases.

The β‐globin promoter −71 C>T mutation is a β+ thalassemic allele

R. Krishnamoorthy, S. Daar, D. Gravell, 2011, European journal of haematology.

Retrospective observational studies: Lights and shadows for medical writers

V. De Sanctis, A. Soliman, C. Kattamis, 2022, Acta bio-medica : Atenei Parmensis.

Recognition, Investigation and Management of Acute Transfusion Reactions: Consensus guidelines for Oman.

L. Wadsworth, S. Daar, M. Al-Khabori, 2014, Sultan Qaboos University medical journal.

Cognitive Function in Adults with Beta-Thalassemia Major in Oman: A Pilot Study

M. Chan, S. Daar, Y. Wali, 2021, Oman medical journal.

Efficacy and Safety of Once-Daily Oral Deferasirox (Exjade ® ) during a Median of 2.7 Years of Treatment in Heavily Iron-Overloaded Patients with β-Thalassemia

G. Damanhouri, A. Taher, A. El‐Beshlawy, 2008 .

Serum Ferritin Levels and Morbidity in β-Thalassemia Intermedia: A 10-Year Cohort Study

M. Cappellini, A. Taher, A. El‐Beshlawy, 2012 .

Evaluation of endocrine complications in beta-thalassemia intermedia (β-TI): a cross-sectional multicenter study

T. Zarei, V. De Sanctis, A. Soliman, 2019, Endocrine.

Multicenter Validation of Spin-Density Projection-Assisted R2-MRI for the Non-Invasive Measurement of Liver Iron Concentration

A. Taher, A. El‐Beshlawy, Mohsen Saleh Elalfy, 2010 .

A Comprehensive Update of ICET-A Network on COVID-19 in Thalassemias: What We Know and Where We Stand

Y. Oymak, T. Zarei, V. De Sanctis, 2020, Acta bio-medica : Atenei Parmensis.

Utility of magnetic resonance imaging t2(*) in diagnosing and monitoring severe cardiac and hepatic siderosis.

A. Pathare, S. Daar, Humoud Al-Dhuhli, 2015, Sultan Qaboos University medical journal.

Deferasirox (Exjade®) Treatment in Pediatric β-Thalassemia Patients with High Iron Burden: 2.8 Years Results from ESCALATOR Trial

G. Damanhouri, A. Taher, Mohsen Saleh Elalfy, 2008 .

Deferasirox (Exjade ® ) Significantly Improves Cardiac T2* in Heavily Iron-Overloaded Patients with β-Thalassemia Major

A. Taher, A. Pathare, S. Daar, 2008 .

Pregnancy Outcomes in Women with Homozygous Beta Thalassaemia: A single-centre experience from Oman.

S. Daar, M. Al-Khaduri, Nihal M Al-Riyami, 2014, Sultan Qaboos University medical journal.

Does Testosterone Replacement Therapy Promote an Augmented Risk of Thrombotic Events in Thalassemia Major Male Patients with Hypogonadism?

V. De Sanctis, A. Soliman, H. Elsedfy, 2017, Indian journal of endocrinology and metabolism.

Deferasirox (Exjade®, ICL670) Treatment of Inadequately Chelated β-Thalassemia Patients from the Middle East: The ESCALATOR Trial.

A. Taher, A. El‐Beshlawy, S. Daar, 2005 .

Rapid iron loading in heart and liver in a patient with transfusion dependent thalassaemia after brief poor compliance with iron chelation therapy.

S. Daar, V. Berdoukas, Saeed Ahmed, 2010, Sultan Qaboos University medical journal.

Magnitude of cumulative iron overload correlates with the severity of anemia in untreated non-transfusion-dependent β-thalassemia

M. Cappellini, A. Taher, A. El‐Beshlawy, 2022, Annals of Hematology.

Selected highlights of the VIII International Symposium of Clinicians for Endocrinopathies in Thalassemia and Adolescent Medicine (ICET-A) on Growth, Puberty and Endocrine Complications in Thalassaemia. Auditorium of the Sultan Qaboos University (SQU) Muscat (Sultanate of Oman), 20th of December 201

V. De Sanctis, A. Soliman, H. Elsedfy, 2015, Pediatric endocrinology reviews : PER.

Validation of a noninvasive pulse CO‐oximetry–based hemoglobin estimation in patients with sickle cell disease

S. Daar, M. Al-Khabori, K. al-Farsi, 2013, International journal of laboratory hematology.

Sustained Protection from Labile Plasma Iron (LPI) with the Once-Daily, Oral Iron Chelator Deferasirox (Exjade®, ICL670) in Iron-Overloaded β-Thalassemia Patients.

A. Taher, A. Pathare, S. Daar, 2006 .

Initiation of Antiretroviral Therapy in the Hospital Is Associated With Linkage to Human Immunodeficiency Virus (HIV) Care for Persons Living With HIV and Substance Use Disorder

L. Metsch, L. Gooden, Yue Pan, 2021 .

Validation of a non-invasive pulse CO-oximetry based hemoglobin estimation in normal blood donors.

S. Daar, M. Al-Khabori, K. al-Farsi, 2014, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

Recent advancements in glucose dysregulation and pharmacological management of osteoporosis in transfusion-dependent thalassemia (TDT): an update of ICET-A (International Network of Clinicians for Endocrinopathies in Thalassemia and Adolescence Medicine)

M. Yavropoulou, V. De Sanctis, S. Daar, 2023, Acta bio-medica : Atenei Parmensis.

Site of subcutaneous desferrioxamine injection is the initial site of post-transfusion urticaria in multi-transfused beta-thalassaemia major patients.

S. Daar, V. Nirmala, K. Ghosh, 2000, Clinical and Laboratory Haematology.

Blood supply challenges and transfusion care of patients with hemoglobinopathies during COVID19 pandemic

S. Daar, A. Al‐Riyami, 2020 .

Assessment of glucose homeostasis in young adult female β-thalassemia major patients (β-TM) with acquired hypogonadotropic hypogonadism (AHH) never treated with sex steroids compared to eugonadal β-TM patients with spontaneous menstrual cycles

V. De Sanctis, A. Soliman, C. Kattamis, 2023, Acta bio-medica : Atenei Parmensis.

Longitudinal study of ICET-A on glucose tolerance, insulin sensitivity and β-cell secretion in eleven β-thalassemia major patients with mild iron overload

V. De Sanctis, A. Soliman, C. Kattamis, 2023, Acta bio-medica : Atenei Parmensis.

Clinical and Laboratory Features of Hemoglobin La Desirade Variant in Association with Sickle Cell and Alpha Thalassemia Genes

A. Pathare, S. Daar, S. Alkindi, 2020, Mediterranean journal of hematology and infectious diseases.

First report of the spectrum of δ‐globin gene mutations in Omani subjects – identification of novel mutations

A. Pathare, S. Alkindi, R. Krishnamoorthy, 2015, International Journal of Laboratory Hematology.

Mortality and complications in Omani patients with beta-thalassemia major: a long-term follow-up study

V. De Sanctis, S. Daar, M. Al-Khabori, 2023, Acta bio-medica : Atenei Parmensis.

Hypomenorrhea in Adolescents and Youths: Normal Variant or Menstrual Disorder ? Revision of Literature and Personal Experience

V. De Sanctis, A. Soliman, C. Kattamis, 2022, Acta bio-medica : Atenei Parmensis.

Unilateral breast enlargement in males during adolescence (10-19 years): review of current literature and personal experience

V. De Sanctis, A. Soliman, C. Kattamis, 2023, Acta bio-medica : Atenei Parmensis.

INVASIVE CANDIDAL LARYNGITIS AS A MANIFISTATION OF CYCLIC NEUTROPENIA IN AN OMANI INFANT

S. Daar, Y. Wali, H. Al-Kindi, 2008, Pediatric hematology and oncology.

An ICET-A survey on occult and emerging endocrine complications in patients with β-thalassemia major: Conclusions and recommendations

V. De Sanctis, A. Soliman, S. A. Al Jaouni, 2019, Acta bio-medica : Atenei Parmensis.

A prospective guide for clinical implementation of selected OGTT-derived surrogate indices for the evaluation of β-cell function and insulin sensitivity in patients with transfusion-dependent β-thalassaemia

V. De Sanctis, F. Saki, S. Daar, 2023, Acta bio-medica : Atenei Parmensis.

Transfusion Consent in Oman: Physicians' Perception at a Tertiary Care University Hospital.

H. Al-Sabti, S. Daar, M. Al-Khabori, 2016, Oman medical journal.

Retrospective study on long-term effects of hormone replacement therapy (HRT) and iron chelation therapy on glucose homeostasis and insulin secretion in female ß- thalassemia major (β-TM) patients with acquired hypogonadotropic- hypogonadism (AHH)

V. De Sanctis, A. Soliman, C. Kattamis, 2023, Acta bio-medica : Atenei Parmensis.

Severity ranking of non‐deletional alpha thalassemic alleles: insights from an Omani family study

N. Fawaz, Siham Alsinani, R. Krishnamoorthy, 2011, European journal of haematology.

A retrospective study of glucose homeostasis, insulin secretion, sensitivity/resistance in non- transfusion-dependent β-thalassemia patients (NTD- β Thal): reduced β-cell secretion rather than insulin resistance seems to be the dominant defect for glucose dysregulation (GD)

V. De Sanctis, S. Daar, Ploutarchos Tzoulis, 2023, Acta bio-medica : Atenei Parmensis.